Clinical Trial Update: A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 study assessing satisfaction with Actonel in postmenopausal women with osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Actonel (risedronate)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED